Can AI replace humans in pharmacovigilance?
Let's continue the conversation started at the World Safety Conference in Boston
Date: April 10, 2025
Time: 10:00-11:00AM US EST / 4:00-5:00 PM CEST
About the webinar
In October 2024, we hosted a roundtable discussion on artificial intelligence (AI) in pharmacovigilance (PV) at the World Safety Conference in Boston. The session sparked insightful conversations and drew a strong audience of delegates eager to participate or listen.
During the discussion, we explored the benefits of AI, such as reducing data entry errors, saving time when creating cases in safety databases, and improving accuracy in listings and summary tabulations. We also addressed key challenges, including software costs, data security concerns, programming errors, and the lack of specific regulations governing AI use in pharmacovigilance.
Unfortunately, time ran out before we could cover everything. However, many attendees expressed a strong interest in continuing the conversation—so that’s exactly what we’ll be doing in this upcoming webinar roundtable discussion!
What we'll discuss
- The benefits of AI in PV, expanding on the conference discussion
- The challenges of AI in PV, expanding on the conference discussion
- The current regulations related to the use of AI in PV
Unable to join? Register and you will receive the recording after the live session.
Meet the host
-
Angie Robertson
Director, Systems and Submissions
View Bio
Angie Robertson
Angie Robertson is an experienced pharmacovigilance subject matter expert with over 23 years’ experience in the pharmacovigilance space. Starting out as a nurse, then moving on to clinical research coordinator, Angie has experienced the clinical side of drug, device and vaccine safety and efficacy.
Learning end to end safety data collection and case processing led to a passion for database configuration and analytics solutions.
Angie’s practical and creative problem-solving skills have contributed to many successful safety data migrations and vendor transitions using Argus and ArisG in a pharmaceutical company setting as well as a CRO.